| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 269.96▲ | 269.73▲ | 270.10▲ | 270.51▼ | 267.69▲ |
| MA10 | 269.53▲ | 270.37▼ | 271.04▼ | 267.10▲ | 267.73▲ |
| MA20 | 269.76▲ | 271.08▼ | 271.66▼ | 267.32▲ | 256.80▲ |
| MA50 | 270.96▼ | 270.27▼ | 267.59▲ | 267.74▲ | 227.59▲ |
| MA100 | 271.30▼ | 266.61▲ | 266.58▲ | 255.46▲ | 199.01▲ |
| MA200 | 267.56▲ | 268.32▲ | 267.79▲ | 231.41▲ | 177.17▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.183▲ | -0.270▼ | -0.533▼ | 0.673▲ | -0.885▼ |
| RSI | 49.853▼ | 47.037▼ | 50.187▲ | 53.661▲ | 66.171▲ |
| STOCH | 96.348▲ | 32.941 | 36.884 | 76.765 | 69.216 |
| WILL %R | -6.122▲ | -53.898 | -66.720 | -22.216▲ | -15.662▲ |
| CCI | 106.639▲ | -28.570 | -73.959 | 76.903 | 65.871 |
|
Tuesday, October 20, 2026 07:00 AM
The fund bought $90.7 million of Tarsus Pharmaceuticals as a new position, part of $516.5 million in gross trading and $80.2 million in net buying.
|
|
Saturday, October 10, 2026 12:07 PM
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings.
|
|
Sunday, October 04, 2026 05:00 PM
The First Trust NYSE Arca Biotechnology Index Fund has outperformed the VanEck Biotech ETF on a one-year basis and over the last five years. The VanEck Biotech ETF offers a lower expense ratio of 0.35 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/10/26 | 271.19 | 271.19 | 268.09 | 270.16 | 37,160 |
| 22/10/26 | 271.63 | 273.24 | 269.56 | 272.68 | 55,300 |
| 21/10/26 | 271.42 | 274.25 | 270.90 | 272.46 | 58,500 |
| 20/10/26 | 266.78 | 272.51 | 266.78 | 271.77 | 82,600 |
| 19/10/26 | 264.38 | 266.31 | 264.38 | 265.48 | 38,600 |
| 16/10/26 | 269.03 | 269.21 | 262.91 | 263.60 | 49,300 |
| 15/10/26 | 265.25 | 269.95 | 265.11 | 268.39 | 55,500 |
| 14/10/26 | 259.00 | 264.26 | 258.81 | 262.95 | 39,800 |
| 13/10/26 | 263.64 | 263.64 | 259.49 | 259.65 | 44,900 |
| 12/10/26 | 265.82 | 266.10 | 263.53 | 263.90 | 26,300 |
|
|
||||
|
|
||||
|
|